Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy

Ryoichi Bessho(Asahikawa Medical University), Tsuguhito Ota(Asahikawa Medical University)
Scientific Reports
October 14, 2019
Cited by 159


Related Papers